Pierre Sayad, executive of Fennec Pharmaceuticals Inc. (TSX:FRX), picked up 12,000 Common Shares at an average of $12.18 — a $146K buy on Sep 4, 2026.
4 other insiders at the company also bought this week. They still hold 9,519 shares — a stake worth roughly $163K at today's price.
FRX shares are trading around $17.10, up 0.0% in the latest session, up 38% over the past three months, and up 64% this year. The stock has ranged from $8.10 to $17.63 over the past 52 weeks and sits within 3% of that high.
